FDA Inspection 904963 — Central Jersey Blood Center, Inc.
The FDA completed an inspection of Central Jersey Blood Center, Inc. on Nov 4, 2014 in Shrewsbury, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 4, 2014
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Shrewsbury, NJ (United States)